États-Unis · Plateformes & données · Finviz

Travere Therapeutics Reports Third Quarter 2026 Financial Results

Publié par Finviz · États-Unis il y a 9 h

(Nasdaq: TVTX) today reported its third quarter 2026 financial results and provided a corporate update. “Strong execution across our business drove another quarter of significant…

Lire l'article complet sur Finviz Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finviz.com)

Travere Therapeutics Reports Third Quarter 2026 Financial Results

À lire aussi

MSA Safety beats top-line estimates; reaffirms FY26 outlook

Kosmos Energy (KOS) Q3 2026 Earnings Call Transcript

SLB (NYSE:SLB) Stock Breaks Below 50 Day Moving Average After Insider Selling

Australian, Chinese airline stocks jump as oil prices plunge more than 7%

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Stock market after midterm elections: What S&P 500 history shows

Travere Therapeutics Reports Third Quarter 2026 Financial Results

Partager

À lire aussi

MSA Safety beats top-line estimates; reaffirms FY26 outlook

Kosmos Energy (KOS) Q3 2026 Earnings Call Transcript

SLB (NYSE:SLB) Stock Breaks Below 50 Day Moving Average After Insider Selling

Australian, Chinese airline stocks jump as oil prices plunge more than 7%

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Stock market after midterm elections: What S&P 500 history shows